Rose, A. A. N., Annis, M. G., Frederick, D. T., Biondini, M., Dong, Z., Kwong, L., . . . Siegel, P. M. (2016). MAPK Pathway Inhibitors Sensitize BRAF Mutant Melanoma to an Antibody-Drug Conjugate Targeting GPNMB. Clin Cancer Res.
Chicago ZitierstilRose, April A. N., et al. "MAPK Pathway Inhibitors Sensitize BRAF Mutant Melanoma to an Antibody-Drug Conjugate Targeting GPNMB." Clin Cancer Res 2016.
MLA ZitierstilRose, April A. N., et al. "MAPK Pathway Inhibitors Sensitize BRAF Mutant Melanoma to an Antibody-Drug Conjugate Targeting GPNMB." Clin Cancer Res 2016.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.